Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Category Archives: MS Treatment
Calculated Treatment Response Score May Help Choose Between MS Therapies – Neurology Advisor
Posted: Published on November 28th, 2020
A treatment response score consisting of a combination of age, sex, relapses in the previous year, disease duration, and Expanded Disability Status Scale (EDSS) could help determine which patients with multiple sclerosis (MS) would benefit from glatiramer acetate or interferon beta-1 (IFN-1a), according to study results published in Neurology. Continue reading
Posted in MS Treatment
Comments Off on Calculated Treatment Response Score May Help Choose Between MS Therapies – Neurology Advisor
Clinical observation experience of a pediatric patient with primary progressive multiple sclerosis in the Moscow office for the treatment of children…
Posted: Published on November 28th, 2020
This article was originally published here Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(10):45-50. Continue reading
Posted in MS Treatment
Comments Off on Clinical observation experience of a pediatric patient with primary progressive multiple sclerosis in the Moscow office for the treatment of children…
Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after…
Posted: Published on November 28th, 2020
This article was originally published here Neurol Sci. 2020 Nov 26. Continue reading
Posted in MS Treatment
Comments Off on Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after…
Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis – DocWire News
Posted: Published on November 28th, 2020
This article was originally published here Neurol Ther. 2020 Nov 26 Continue reading
Posted in MS Treatment
Comments Off on Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis – DocWire News
Treatment Start to Full Effect of Immunotherapies for MS – Medscape
Posted: Published on November 28th, 2020
Izanne Roos1,2, Emmanuelle Leray3, Federico Frascoli4, Romain Casey58, J. William L. Brown9, Dana Horakova10, Eva K Continue reading
Posted in MS Treatment
Comments Off on Treatment Start to Full Effect of Immunotherapies for MS – Medscape
Inflammatory Activity and Treatment Response in Pediatric Compared to Adult Multiple Sclerosis: A Pilot, Retrospective and Observational Study of the…
Posted: Published on November 28th, 2020
This article was originally published here Acta Med Port. 2020 Nov 24. Continue reading
Posted in MS Treatment
Comments Off on Inflammatory Activity and Treatment Response in Pediatric Compared to Adult Multiple Sclerosis: A Pilot, Retrospective and Observational Study of the…
MediciNova Announces Positive Optical Coherence Tomography Results from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS Published…
Posted: Published on November 28th, 2020
LA JOLLA, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that positive Optical Coherence Tomography (OCT) results from the SPRINT-MS Phase 2b trial of MN-166 (ibudilast) in progressive multiple sclerosis (progressive MS) were published in Multiple Sclerosis Journal. Continue reading
Posted in MS Treatment
Comments Off on MediciNova Announces Positive Optical Coherence Tomography Results from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS Published…
Informing the Development of a Digital Health Platform Through Universal Points of Care: Qualitative Survey Study – DocWire News
Posted: Published on November 28th, 2020
JMIR Form Res. 2020 Nov 26;4(11):e22756. doi: 10.2196/22756. Continue reading
Posted in MS Treatment
Comments Off on Informing the Development of a Digital Health Platform Through Universal Points of Care: Qualitative Survey Study – DocWire News
Early Use of Ocrevus Best for Slowing PPMS Progression, Long-term… – Multiple Sclerosis News Today
Posted: Published on November 28th, 2020
Early and continuous use ofOcrevus(ocrelizumab) significantly slows disability progression and delays the time until wheelchair reliance in people with primary progressive multiple sclerosis (PPMS), new Phase 3 data spanning more than six years show. Findings fromthe ORATORIO trial, comparing immediate use with a two-year delay, support Ocrevus sustained and long-term benefits, and highlight gains realized through earlier treatment initiation in PPMS patients Continue reading
Posted in MS Treatment
Comments Off on Early Use of Ocrevus Best for Slowing PPMS Progression, Long-term… – Multiple Sclerosis News Today
MS News That Caught My Eye Last Week: Typing Patterns and MS… – Multiple Sclerosis News Today
Posted: Published on November 28th, 2020
This is an interesting concept that makes sense. Like the nine-hole peg test that some neurologists use to test finger dexterity, and like some apps that attempt to measure this, monitoring how quickly, and in what manner I can move my fingers might allow a physician to track the progression of my disease. It could be done remotely and frequently Continue reading
Posted in MS Treatment
Comments Off on MS News That Caught My Eye Last Week: Typing Patterns and MS… – Multiple Sclerosis News Today